Genetically engineered pigs as models for human disease
- PMID: 29419487
- PMCID: PMC5818075
- DOI: 10.1242/dmm.030783
Genetically engineered pigs as models for human disease
Abstract
Genetically modified animals are vital for gaining a proper understanding of disease mechanisms. Mice have long been the mainstay of basic research into a wide variety of diseases but are not always the most suitable means of translating basic knowledge into clinical application. The shortcomings of rodent preclinical studies are widely recognised, and regulatory agencies around the world now require preclinical trial data from nonrodent species. Pigs are well suited to biomedical research, sharing many similarities with humans, including body size, anatomical features, physiology and pathophysiology, and they already play an important role in translational studies. This role is set to increase as advanced genetic techniques simplify the generation of pigs with precisely tailored modifications designed to replicate lesions responsible for human disease. This article provides an overview of the most promising and clinically relevant genetically modified porcine models of human disease for translational biomedical research, including cardiovascular diseases, cancers, diabetes mellitus, Alzheimer's disease, cystic fibrosis and Duchenne muscular dystrophy. We briefly summarise the technologies involved and consider the future impact of recent technical advances.
Keywords: Disease models; Genetic modification; Pig; Swine.
© 2018. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interestsThe authors declare no competing or financial interests.
Figures



References
-
- Al-Mashhadi R. H., Sorensen C. B., Kragh P. M., Christoffersen C., Mortensen M. B., Tolbod L. P., Thim T., Du Y., Li J., Liu Y. et al. (2013). Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci. Transl. Med. 5, 166ra1 10.1126/scitranslmed.3004853 - DOI - PubMed
-
- Al-Mashhadi R. H., Bjorklund M. M., Mortensen M. B., Christoffersen C., Larsen T., Falk E. & Bentzon J. F. (2015). Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. Diabetologia 58, 1926-1936. 10.1007/s00125-015-3637-1 - DOI - PubMed
-
- Albuquerque C., Breukel C., van der Luijt R., Fidalgo P., Lage P., Slors F. J., Leitao C. N., Fodde R. and Smits R. (2002). The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum. Mol. Genet. 11, 1549-1560. 10.1093/hmg/11.13.1549 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources